Shanghai Brattea Medical Technology’s Series D Investment Round

Fangda represented Shanghai Brattea Medical Technology Co., Ltd. on the deal.Shanghai Brattea Medical Technology Co., Ltd. completed its series D investment round. The transaction was closed…

This content is for Standard 1 Year members only.
Login Join Now

Karyopharm’s Refinancing Transactions and Amended Royalty Agreement

Corelight’s $150 Million Series E Funding Round

Daré Bioscience’s $22 Million Non-Dilutive Strategic Royalty Financing

Reuse’s US$4,51 Million Financing Round

Accenture Song’s Acquisition of Soko

Comerc Energia’s R$2 Billion Debentures Issuance

Lakestar’s Closing Of Lakestar Early IV And Lakestar Growth II Funds

Varco Energy Ltd’s Acquisition Of Sambar Power Battery Storage Project From Carlton Power Ltd

CoreLogic’s Acquisition Of Parity Projects

JS Virginia Proprietary Ltd’s Financing Of Renewable Project In South Africa

Injaro Investment Advisors’ Equity Investment in NME

Dislog Group’s Acquisition of CMB Plastique Maroc

OSN’s Acquisition of a Control Stake in Anghami

McLaren’s Successful Reorganisation with Mumtalakat

Skyports Infrastructure’s Dubai Launch

Salmon’s $25 Million Series A-1 Financing

Dalian Wanda Commercial Management’s $8.3bn Investment Agreement with Zhuhai Wanda Commercial Management

DP World’s Acquisition of Cargo Services Seafreight

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

BCLP Makes New Leadership Appointments

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

Intellectual Property Partner Jeff Morton Joins Haynes Boone in Southern California

Shanghai Brattea Medical Technology’s Series D Investment Round

Author: Maha Kanaan